• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

The Weekly Roundup: June 17-21


In case you missed it, this week we had news about the FDA approval of sofpironium gel for primary axillary hyperhidrosis, Sun Pharma's "I LUV YA for the Long Haul" psoriasis campaign, the role of laser treatments in preventing cancer, and more.

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Addressing the Health Impacts of a Changing Climate

Ethan Sims, MD, spoke with Dermatology Times on having positive conversations, cutting down on waste, and how to get involved in change.

The Role of Store-and-Forward Teledermatology in Dermatologic Emergency Units: A Comparative Study

Dermatologic emergency units are increasingly overwhelmed by rising patient volumes and reduced resources, but store-and-forward teledermatology offers an effective alternative.

Patient and Expert Perspectives From the “I LUV YA for the Long Haul” Plaque Psoriasis Campaign

Omar Noor, MD, and a patient with psoriasis share their unique perspectives on moderate to severe plaque psoriasis treatment with tildrakizumab.

Recognizing Barriers to Access Psoriasis Biologics

A recent review found that disparities and barriers, such as income, age, and location, can impede patient access to necessary care.

Fetal and Maternal Factors Must Be Considered In Melanoma Management, ASCO Posters Argue

Cutaneous and advanced stage melanomas present significant challenges during pregnancy, according to the posters.

Psoriasis and Sunburn: New Study Highlights Increased Risk and Clinical Implications

Sara Osborne, a fourth-year medical student and the lead author on the study, spoke with Dermatology Times on key findings and explain the need for further investigation.

Visual Racism and Racial Bias Persist in Dermoscopy Imaging

In one study, less than 5% of images from a HAM10000 database came from patients with darker skin types.

Facial Redness Reduction Cosmetics

In this month's Cosmetic Conundrums column, Zoe Diana Draelos, MD, examines the most popular active ingredients in redness-reducing formulations.

Modern Dermatology: Advanced Meds and Social Media Myths

Rob Casquejo, PA-C, spoke with Dermatology Times on new and upcoming medications, addressing unmet needs, and social media misinformation.

Alexandra Golant, MD: Insights from Olympic Athlete Suni Lee's Journey with Atopic Dermatitis

Eli Lilly recently hosted a panel discussion with Olympic athlete Suni Lee to discuss the importance of finding a dermatologist who understands the burden of AD.

The Role of Laser Treatments in Preventing Skin Cancer

Patricia Richey, MD, delves into efficacy of the 1927 and 1550 nanometer lasers to prevent skin cancers.

Residency Is Ending Soon: Key Financial Tips for Your Next Chapter

From a financial perspective, the change from resident to attending dermatologist may be profound.

Laura Bush on Dermatology PA Advancements

Laura Bush reflects on her term as SDPA president, discussing achievements, challenges, and the future of dermatology PAs in health care.

Research Finds Poor Awareness and Photoprotective Behaviors Among Individuals With Albinism in Nigeria

Individuals in Uyo, Nigeria, with albinism are at great risk of developing photodermatoses due to a lack of photoprotection and awareness of photoprotective behaviors.

Correlations Detected Between Transepidermal Water Loss and Barrier Repair Kinetics, Heart Rate Variability

Perceived stress, however, did not exhibit any correlations with psycho- and skin physiological parameters.

AI-Enabled Devices Equip PCPs to Provide Specialty Care

The authorization of DermaSensor marks a milestone in AI-enabled devices, highlighting opportunities and challenges in their integration into clinical practice.

Seth Matarasso, MD, Addresses Counterfeit Botox News and How to Move Forward

The recent news of counterfeit Botox resulted in patients with blurred vision, difficulty swallowing, shortness of breath, and additional symptoms.

I Charged My Patient: I Was Sued

This month's Legal Eagle column explores if a dermatologist can be sued for charging a fee for providing medical records in a lawsuit.

Beyond Aesthetics: The Vital Role of Nails in Health

Martin Zaiac, MD, gave insight on potential risks associated with manipulation of nails, hygiene, and when it is necessary to see a specialist.

Benzoyl Peroxide May Be Used as Infection-Prevention Antiseptic in Dermatologic Surgery

BPO may prevent post-operative infections with limited risk of microbial resistance in surgery of sebaceous areas, according to a new study.

Line-Field Confocal Optical Coherence Tomography Offers Non-Invasive Assessment of Subclinical Features and Treatment Interactions

LC-OCT non-invasively assessed non-structural changes from botulinum toxin and irreversible tissue changes from microwave thermolysis in hyperhidrosis.

Top Secrets to Shield Your Patients From Eczema and Allergies

Learn more about the proven strategies to keep your pediatric patients' skin healthy and allergy-free.

SFA-002 Shows Promise in Early Clinical Trial Psoriasis Cohorts

Stefan Weiss, MD, MBA, explains next steps for the oral treatment after the completion of phase 1b enrollment.

Red Fluorescence Highlights Microbial Composition Variability in Androgenetic Alopecia

Researchers noted differences in microbial evenness, abundance composition, and functional prediction.

Antimicrobial Resistance: Challenges and Potential Solutions

Stephen Tyring, MD, PhD, MBA, covers the burden of antimicrobial resistance and the need for alternative treatments.

FDA Approves Sofpironium (Sofdra) as First and Only Chemical Entity for Primary Axillary Hyperhidrosis

Botanix Pharmaceuticals announced the approval of its sofpironium topical gel, 12.45% for adults and children ages 9 and older.

Lebrikizumab Maintains EASI 90 Responses up to 38 Weeks After Discontinuation

The post-hoc analysis evaluated the relationship between lebrikizumab serum concentration levels and sustained clinical response after lebrikizumab discontinuation.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.